Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of ustekinumab in Chinese adults with plaque psoriasis
ChiCTR2500098963Phase 4Recruiting
- Sponsor
- First Hospital of China Medical University
- Start
- Dec 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ustekinumab in plaque psoriasis, sponsored by First Hospital of China Medical University. Primary endpoint: PASI 75 at Week 16. Started Dec 2024; status: recruiting.
02
Drugs
ustekinumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on ChiCTR2500098963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098963.